Citadel Advisors LLC 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:47 pm Sale | 2026-03-31 | 13G | ALLOGENE THERAPEUTICS INC ALLO | Citadel Advisors LLC | 6,855,120 2.800% | -6,491,031 (-48.64%) | Filing |
| 2025-07-16 6:02 pm Purchase | 2025-07-09 | 13G | ALLOGENE THERAPEUTICS INC ALLO | Citadel Advisors LLC | 13,346,151 6.100% | 13,346,151 (New Position) | Filing |